The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Published: October 25, 2018 at 02:00AM
from NYT Health https://ift.tt/2Sj05PK
The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Published: October 25, 2018 at 02:00AM
from NYT Health https://ift.tt/2Sj05PK
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)